COM:VAXCYTE

Vaxcyte

Stock

USD

Last Close

88.39

22/11 21:00

Market Cap

8.81B

Beta: -

Volume Today

1.61M

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
average inventory						-500K -
average payables		3.10M -	16.58M 434.34%	18.27M 10.20%	8.28M 54.70%	12.19M 47.30%
average receivables						500K -
book value per share	-2.26 -	-4.16 84.27%	11.71 381.69%	5.47 53.27%	14.70 168.71%	0.01 99.91%
capex per share	-0.07 -	-0.05 32.64%	-0.04 16.26%	-0.13 222.95%	-0.09 28.60%	-0.00 99.82%
capex to depreciation	-1.71 -	-0.97 43.30%	-0.82 15.25%	-1.90 130.66%	-0.64 66.46%	-1.58 148.33%
capex to operating cash flow	0.06 -	0.03 56.47%	0.02 2.28%	0.05 117.99%	0.03 36.52%	0.05 57.88%
capex to revenue
cash per share	2.58 -	2.30 10.76%	13.07 467.36%	4.74 63.76%	14.36 203.04%	0.01 99.92%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets	0.01 -	0.00 62.12%		0.05 -	0.02 65.54%	0.02 16.41%
debt to equity	-0.01 -	-0.00 80.92%		0.06 -	0.02 68.16%	0.02 25.22%
dividend yield			0.00 -
earnings yield	-0.04 -	-0.08 81.44%	-0.11 39.97%	-0.08 27.57%	-0.08 4.93%	-0.00 99.91%
enterprise value	603.77M -	610.59M 1.13%	398.83M 34.68%	1.18B 196.62%	2.29B 93.93%	6.10T 265,839.26%
enterprise value over ebitda	-21.25 -	-12.49 41.20%	-4.59 63.25%	-12.04 162.14%	-12.09 0.43%	-13.04K 107,731.20%
ev to operating cash flow	-19.82 -	-12.95 34.65%	-8.55 33.96%	-9.75 13.93%	-13.45 37.99%	-20.56K 152,763.78%
ev to sales
free cash flow per share	-1.26 -	-1.89 49.94%	-1.62 14.36%	-2.46 52.37%	-2.72 10.36%	-0.00 99.88%
free cash flow yield	-0.05 -	-0.07 49.94%	-0.06 15.71%	-0.10 70.18%	-0.06 45.24%	-0.00 99.91%
graham net net	-2.44 -	-4.42 81.13%	11.48 359.87%	3.96 65.50%	13.55 241.99%	0.01 99.93%
graham number	7.64 -	13.98 82.85%	27.98 100.15%	15.40 44.95%	34.95 126.92%	0.03 99.90%
income quality	1.03 -	0.94 9.24%	0.52 44.27%	1.21 132.09%	0.76 37.07%	0.74 3.35%
intangibles to total assets	0 -	0	0	0	0	0
interest coverage	-473.77 -	-1.35K 185.75%	-12.80K 845.27%	-14.81K 15.73%	-116.13K 684.12%
interest debt per share	0.02 -	0.01 62.29%	0.00 96.98%	0.32 136,388.56%	0.28 14.47%	0.00 99.89%
inventory turnover
invested capital	-0.01 -	-0.00 80.92%		0.06 -	0.02 68.16%	0.02 25.22%
market cap	669.40M -	669.40M 0%	785.03M 17.27%	1.24B 57.35%	3.11B 151.85%	6.10T 196,033.08%
net current asset value	-61.86M -	-110.35M 78.38%	342.02M 409.95%	216.03M 36.84%	889.99M 311.98%	928.50M 4.33%
net debt to ebitda	2.31 -	1.20 47.89%	4.45 269.42%	0.53 88.05%	4.30 710.25%	0.79 81.72%
net income per share	-1.15 -	-2.09 81.44%	-2.97 42.22%	-1.93 35.15%	-3.69 91.62%	-0.00 99.89%
operating cash flow per share	-1.19 -	-1.84 54.75%	-1.58 14.31%	-2.34 48.15%	-2.63 12.47%	-0.00 99.88%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets	-0.42 -	-0.81 95.54%	-0.22 72.55%	-0.31 38.03%	-0.24 22.82%	-0.29 19.96%
revenue per share
roe	0.51 -	0.50 1.53%	-0.25 150.49%	-0.35 38.77%	-0.25 28.69%	-0.32 29.04%
roic	0.76 -	0.54 28.06%	-0.25 146.92%	-0.33 28.04%	-0.25 22.90%	-0.36 43.17%
sales general and administrative to revenue
shareholders equity per share	-2.26 -	-4.16 84.27%	11.71 381.69%	5.47 53.27%	14.70 168.71%	0.01 99.91%
stock based compensation to revenue
tangible asset value	-57.73M -	-106.37M 84.27%	345.84M 425.12%	284.02M 17.88%	953.61M 235.76%	1.24B 30.08%
tangible book value per share	-2.26 -	-4.16 84.27%	11.71 381.69%	5.47 53.27%	14.70 168.71%	0.01 99.91%
working capital	59.95M -	50.67M 15.48%	342.14M 575.22%	227.63M 33.47%	902.03M 296.27%	950.62M 5.39%

All numbers in USD (except ratios and percentages)